Skip to content

Clinical trials

Recruiting Glycogen Storage Disease Type II trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Status: Recruiting Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20091
20161
20221
20242
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University2
Genzyme, a Sanofi Company2
Amicus Therapeutics1
AskBio Inc1
Denali Therapeutics Inc.1
Sanofi1
Shionogi1
University of Missouri-Columbia1
xCures1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II11
Amyotrophic Lateral Sclerosis2
Glycogen Storage Disease2
Myasthenia Gravis2
Neuromuscular Diseases2
Rare Diseases2
Alzheimer Disease1
Amyloidosis1
Anemia, Sickle Cell1
Charcot-Marie-Tooth Disease1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.